Keane's Corner VL

Discussion on the AQUARiUS and EXCAAPE studies- Thomas Keane

Details
(Length of discussion ~ 13 minutes) Thomas Keane, MD reviews three state of the art presentations from the 2017 European Society for Medical Oncology (ESMO) meeting. Dr. Keane highlights the AQUARiUS study presented by Antoine Thiery-Vuillemin who overviewed the initial results from this patient reported outcomes (PROs) study among men receiving either abiraterone + prednisone or enzalutamide. The...

ESMO 2017: Prostate Cancer Highlights

Details
(Length of discussion ~ 36 minutes) Thomas Keane reviews recent data presented at the ESMO 2017 conference focusing on advanced prostate cancer and the addition of abiraterone to androgen deprivation therapy as well as the results of the STAMPEDE and LATITUDE trials. Highlighting a number of presentations, he focuses on one in particular “Adding abiraterone acetate plus prednisone or docetaxel for...

STAMPEDE and LATITUDE Trials: Issues to Consider - Thomas Keane

Details
Biograhy: Thomas E. Keane Related Content: LATITUDE abstract from ASCO 2017 STAMPEDE abstract from ASCO 2017 STAMPEDE - Clinical Trial Information A Clinical Conversation with Alicia Morgans and Charles Ryan: Considerations of ASCO 2017 LATITUDE and STAMPEDE Crashing into progress: New findings meet old habits

Evolution of the Mesh Problem - Eric Rovner

Details
Mesh changed the field of Female Pelvic Medicine & Reconstructive Surgery (FPMRS) and continues to change the field - "Evolution" of the Mesh Problem Biographies: Thomas E. Keane Eric S. Rovner, MD Related Content: Short-term complications associated with use of transvaginal mesh

ASCO 2017: Discussion of LATITUDE and STAMPEDE Trials

Details
Discussion about LATITUDE and STAMPEDE trials from the 2017 ASCO annual meeting in Chicago, Illinois - June 2 - 6, 2017 Biography: Thomas E. Keane Related Content: Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy LATITUDE abstract from ASCO 2017 STAMPEDE abstract from ASCO 2017 STAMPEDE - Cli...

Active Surveillance: Protecting Patients From Harm- Laurence Klotz

Details
Protecting Patients From Harm - Active Surveillance Biographies: Thomas E Keane Laurence Klotz, MD Related Content: Active Surveillance in PCa+ Active surveillance in prostate cancer: a critical review

Tom Keane Highlights Notable SUO 2016 Presentations

Details
Tom Keane, MD reviews three state of the art presentations from Society of Urologic Oncology Meeting (SUO) December 2016. First Dr. Keane desribes a state of the art lecture given by Martin Gleeve, MD. Read the report from the session here - State of the Art lecture: Genomic profiling and clinical implications of atypical intermediate prostate cancer phenotype - Dr. Keane then provides an overview...

SIU 2016: 36th Congress Highlights

Details
This editon of Keane's Corner reviews the top sessions from the SIU 2016 including prostate cancer and urothelial cancer. Visit UroToday's SIU Conference Highlights Section for additional content Biography: Thomas E. Keane, MBBCh, FRCSI, FACS, is Professor and Chairman of the Department of Urology at the Medical University of South Carolina in Charleston. Dr. Keane specializes in managing prostate...

Journal Club: Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist

Details
Thomas Keane provides a journal club review on the article, "Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormones Agonist and an Antagonist", published in the European Association of Urology. The hypothesis and approach for this article includes a discussion around if a GnRH antagonist produce the same risk of cardiovascular complication when compared to an LHRH agonist. Also,...

Role of the Gonadotrophin-Releasing Hormone Antagonists and Advanced Hormone-Dependent Prostate Cancer - Journal review

Details
This edition of Keane’s Corner is a Journal Club discussion on the article, “The Role of the Gonadotrophin-Releasing Hormone Antagonists in the Treatment of Patients with Advanced Hormone-Dependent Prostate Cancer in the UK”, published in the World Journal of Urology. Authors: Derek J. Rosario, Patrick Davey, James Green, Damien Greene, Bruce Turner, Heather Payne and Mike Kirby An overview of the...